CIK 0000812796
- Non-accelerated filer
- Smaller reporting company
SOLIGENIX, INC.
Sign in to watch- Ticker
- SNGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 411505029
- Phone
- +1 609-538-8200
- Business address
- 29 EMMONS DRIVE, SUITE B-10, PRINCETON, NJ, 08540
- Former names
- SOLIGENIX, INC., DOR BIOPHARMA INC, ENDOREX CORP, IMMUNOTHERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2010-09-23 | LAPOINTE ANTHONY GREGG Director | Grant or award · Stock Option (Right to Buy) | +187,500 | 187,500 | ||
| 2010-09-23 | THOMPSON VIRGIL Director | Grant or award · Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2010-09-23 | HOWSON TAMAR D Director | Grant or award · Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2010-08-18 | BAM Management LLC 10% owner | Purchase | −160,000 | $0.24 | $38K | 21,766,092 |
| 2010-08-18 | BAM Management LLC 10% owner | Sale | −192,314 | $0.24 | $46K | 21,573,778 |
| 2010-06-18 | LAPOINTE ANTHONY GREGG Director | Purchase | +975,610 | $0.21 | $200K | 975,610 |
| 2010-06-18 | RUBIN ROBERT J. Director | Purchase | +243,902 | $0.21 | $50K | 243,902 |
| 2010-06-18 | CAVAZZA CLAUDIO 10% owner | Purchase | +8,608,580 | $0.21 | $1.8M | 54,227,816 |
| 2010-06-18 | CAVAZZA CLAUDIO 10% owner | Other acquisition · Common Stock Warrant (warrant to buy) | +1 | 1 | ||
| 2010-06-18 | CAVAZZA PAOLO 10% owner | Purchase | +8,608,580 | $0.21 | $1.8M | 54,227,816 |
| 2010-06-18 | CAVAZZA PAOLO 10% owner | Purchase | +2,926,829 | $0.21 | $600K | 3,282,929 |
| 2010-06-18 | CAVAZZA PAOLO 10% owner | Other acquisition · Common Stock Warrant (warrant to buy) | +1 | 1 | ||
| 2010-06-18 | CAVAZZA PAOLO 10% owner | Other acquisition · Common Stock Warrant (warrant to buy) | +1 | 1 | ||
| 2010-06-18 | SIGMA TAU FINANZIARIA SPA 10% owner | Purchase | +8,608,580 | $0.21 | $1.8M | 54,227,816 |
| 2010-06-18 | SIGMA TAU FINANZIARIA SPA 10% owner | Other acquisition · Common Stock Warrant (right to buy) | +1 | 1 | ||
| 2009-10-09 | Biotex Pharma Investments, LLC 10% owner | Returned to the company | −335,000 | $0.32 | $106K | 17,665,000 |
| 2009-10-08 | Rubin Robert Joseph Director | Grant or award · Stock Options (right to buy) | +300,000 | 300,000 | ||
| 2009-10-01 | Biotex Pharma Investments, LLC 10% owner | Returned to the company | −750,000 | $0.31 | $232K | 18,000,000 |
| 2009-09-28 | Biotex Pharma Investments, LLC 10% owner | Returned to the company | −250,000 | $0.26 | $66K | 18,750,000 |
| 2009-09-28 | SCHABER CHRISTOPHER J Chief Executive Officer | Purchase | +79,051 | $0.25 | $20K | 471,817 |
Page 15 of 22 · 422 trades